Details of the Drug

General Information of Drug (ID: DMN3C2I)

Drug Name
CAR-T cells targeting EphA2
Indication
Disease Entry ICD 11 Status REF
Malignant glioma 2A00.0 Phase 1/2 [1]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D05OHY

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ephrin type-A receptor 2 (EPHA2) TTRJB2G EPHA2_HUMAN CAR-T-Cell-Therapy [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02575261) CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients